Table 3. Correlations between baseline sortilin levels and lipid parameters.
All patients |
Pitavastatin |
Pravastatin |
||||
---|---|---|---|---|---|---|
r | p value | r | p value | r | p value | |
Baseline level | ||||||
Total cholesterol | 0.118 | 0.27 | 0.229 | 0.13 | −0.004 | 0.98 |
LDL cholesterol | 0.104 | 0.33 | 0.133 | 0.39 | 0.026 | 0.87 |
Triglycerides | −0.032 | 0.76 | 0.220 | 0.15 | −0.267 | 0.07 |
HDL cholesterol | −0.023 | 0.83 | −0.106 | 0.5 | 0.048 | 0.75 |
Hetero-dimer PCSK9 | 0.085 | 0.43 | 0.084 | 0.59 | 0.094 | 0.54 |
Percentage change | ||||||
Total cholesterol | 0.008 | 0.94 | −0.035 | 0.82 | −0.113 | 0.45 |
LDL cholesterol | 0.039 | 0.71 | 0.124 | 0.42 | −0.166 | 0.27 |
Triglycerides | 0.119 | 0.26 | −0.047 | 0.76 | 0.159 | 0.29 |
HDL cholesterol | 0.052 | 0.63 | −0.026 | 0.87 | 0.074 | 0.63 |
Hetero-dimer PCSK9 | 0.020 | 0.85 | −0.286 | 0.06 | 0.110 | 0.47 |
LDL, low-density lipoprotein; HDL, high-density lipoprotein; PCSK9, proprotein convertase subtilisin/kexin type 9.